How to buy Lexaria Bioscience shares | $6.79

Own Lexaria Bioscience shares in just a few minutes. Share price changes are updated daily.

Lexaria Bioscience Corp (LEXX) is a leading packaged foods business based in Canada. In the week up to 6 June Lexaria Bioscience shares surged 13.65% to a closing position of $6.91. Over the last 12 months, Lexaria Bioscience's share price has risen by a staggering 2,178.52% from $0.298. Lexaria Bioscience is listed on the NASDAQ and employs 4 staff. All prices are listed in US Dollars.

How has coronavirus impacted Lexaria Bioscience's share price?

Since the stock market crash that started in February 2020, Lexaria Bioscience's share price has had significant positive movement.

Its last market close was $6.08, which is 92.11% up on its pre-crash value of $0.48 and 2,549.24% up on the lowest point reached during the March 2020 crash when the shares fell as low as $0.2295.

If you had bought $1,000 worth of Lexaria Bioscience shares at the start of February 2020, those shares would have been worth $662.92 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $12,666.65.

Lexaria Bioscience share price

Use our graph to track the performance of LEXX stocks over time.

Lexaria Bioscience shares at a glance

Information last updated 2021-06-18.
Open$6.78
High$6.797
Low$6.5586
Close$6.79
Previous close$6.88
Change $-0.09
Change % -1.3081%
Volume 64,273
Information last updated 2021-06-17.
52-week range$4.11 - $12.9
50-day moving average $6.0743
200-day moving average $5.8234
Dividend yield N/A (0%)
Earnings per share (TTM) N/A
Promoted
eToro Free Stocks

Invest in Lexaria Bioscience shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Name Product Ratings Finder rating Customer rating Min. initial deposit Price per trade Frequent trader rate Platform fee Offer Link
Hargreaves Lansdown Fund and Share Account
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£1
£11.95
£5.95
£0

Capital at risk

Platform details
FREE TRADES
eToro Free Stocks
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
$200
£0
N/A
£0

Capital at risk

Platform details
FREE TRADES
Stake
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£50
US: £0
N/A
£0
Join and receive a free share worth up to £100

Capital at risk

Platform details
Degiro Share Dealing
Finder score
★★★★★
★★★★★
Expert analysis
Not yet rated
£0.01
UK: £1.75 + 0.014% (max £5)
US: €0.50 + $0.004 per share
N/A
£0

Capital at risk

Platform details
interactive investor Trading Account
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£0
£7.99 (with one free trade per month)
N/A
£9.99 per month

Capital at risk

Platform details
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Lexaria Bioscience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Lexaria Bioscience price performance over time

Historical closes compared with the last close of $6.79

1 week (2021-06-08) -3.28%
1 month (2021-05-19) 25.74%
3 months (2021-03-19) 12.42%
6 months (2020-12-18) 2,536.89%
1 year (2020-06-19) 2,241.38%
2 years (2019-06-19) 662.92%
3 years (2018-06-19) 192.67%
5 years (2016-06-16) 7,436.07%

Financials

Revenue TTM $772,574
Gross profit TTM $276,925
Return on assets TTM -32.31%
Return on equity TTM -35.13%
Profit margin 0%
Market capitalisation $34.5 million

TTM: trailing 12 months

How to short and sell Lexaria Bioscience shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "LEXX.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 398,204 Lexaria Bioscience shares held short by investors – that's known as the "short interest". This figure is 14.8% down from 467,290 last month.

There are a few different ways that this level of interest in shorting Lexaria Bioscience shares can be evaluated.

Short interest ratio (SIR)

Lexaria Bioscience's "short interest ratio" (SIR) is the quantity of Lexaria Bioscience shares currently shorted divided by the average quantity of Lexaria Bioscience shares traded daily (recently around 2.5 million). Lexaria Bioscience's SIR currently stands at 0.16. In other words for every 100,000 Lexaria Bioscience shares traded daily on the market, roughly 160 shares are currently held short.

However Lexaria Bioscience's short interest can also be evaluated against the total number of Lexaria Bioscience shares, or, against the total number of tradable Lexaria Bioscience shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Lexaria Bioscience's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Lexaria Bioscience shares in existence, roughly 80 shares are currently held short) or 0.105% of the tradable shares (for every 100,000 tradable Lexaria Bioscience shares, roughly 105 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Lexaria Bioscience.

Find out more about how you can short Lexaria Bioscience stock.

Lexaria Bioscience share dividends

We're not expecting Lexaria Bioscience to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Share price volatility

Over the last 12 months, Lexaria Bioscience's shares have ranged in value from as little as $4.11 up to $12.9. A popular way to gauge a stock's volatility is its "beta".

LEXX.US volatility(beta: 1.66)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lexaria Bioscience's is 1.6641. This would suggest that Lexaria Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site